PCRX News - Candlesense

PharmaCorp Rx Inc. Reports Q2 2025 Financial Results

SASKATOON, Saskatchewan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a growing national platform for pharmacist-led community pharmacy ow...

Are there any macro‑economic or regulatory factors highlighted in the release that could affect PharmaCorp's operating environment moving forward? How does the reported sentiment score of 10 align with market perception, and could it lead to increased analyst coverage or investor interest? Did the release mention any strategic initiatives (e.g., expansion plans, technology investments, or partnership agreements) that could influence future growth and market positioning?

Earnings

14 days ago

PharmaCorp Rx Inc. Announces New Credit Facilities With CIBC and Unveils Pharmacist Co-Ownership Financing Initiative

SASKATOON, Saskatchewan, Aug. 13, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has entered into a credit agreement w...

Does the involvement of CIBC as a lender signal any strategic partnership or preferential terms that could benefit PharmaCorp? How will the market likely react to this announcement in terms of trading volume and price movement? What are the potential risks if PharmaCorp fails to meet the credit facility covenants or if acquisition integration does not go as planned?

Finance

16 days ago

PACIRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Pacira BioSciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Pacira BioSciences, Inc. (N...

Lawsuits

2 months ago